Literature DB >> 11354516

Palate vault morphology in Down syndrome.

A Panchón-Ruiz1, V Jornet-Carrillo, F Sanchez del Campo.   

Abstract

Moire topography was used to quantitatively determine the shape of the palatal vault in 57 Spanish patients with Down syndrome (DS) (38 males and 19 females; age range 18-36 years) and in 100 normal controls (N) (76 males and 24 females; age range 20-29 years). The topographic image for each palatal vault was analyzed and approximately 40 sets of coordinates (x, y, z) were recorded. Other parameters, including length, width and maximum height, were recorded from the palate vault images. No appreciable sexual dimorphism in palate dimensions was observed in DS subjects versus the situation in N subjects. Globally, the average N dimensions were significantly greater than those in the DS patients (P < 0.005). A special palatal morphology was found to be associated with DS, with different ratios for the three dimensions (mean factor 0.88 for length, 0.81 for width and 0.73 for height), versus the healthy palatal vaults. It is concluded that palatal morphology in DS fits an elliptic paraboloid. On the other hand, no lineal correlation was observed between height, width and length in the DS and N groups. The scatter plots of bivariate data exhibited a shapeless morphology. The lineal correlation coefficients ranged from 0.008 to 0.33 for the DS and N groups.

Entities:  

Mesh:

Year:  2000        PMID: 11354516

Source DB:  PubMed          Journal:  J Craniofac Genet Dev Biol        ISSN: 0270-4145


  2 in total

1.  Growth of the hard palate in infants with Down syndrome compared with healthy infants-A retrospective case control study.

Authors:  Daniel Klingel; Ariane Hohoff; Robert Kwiecien; Dirk Wiechmann; Thomas Stamm
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

2.  Homo sapiens, Chimpanzees and the Enigma of Language.

Authors:  Ambrosio Bermejo-Fenoll; Alfonso Panchón-Ruíz; Francisco Sánchez Del Campo
Journal:  Front Neurosci       Date:  2019-05-31       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.